Search for: "Mylan Pharmaceuticals"
Results 441 - 460
of 739
Sorted by Relevance
|
Sort by Date
28 Aug 2013, 10:31 am
By Dennis Crouch Leo Pharmaceutical Products, Ltd. v. [read post]
16 Mar 2022, 9:57 am
Mylan Pharmaceuticals (Fed. [read post]
25 Jul 2008, 11:56 pm
Digitek is distributed by Mylan Pharmaceuticals, Inc. under a "Bertek" label and by UDL Laboratories, Inc. under a "UDL" label.The voluntary recall of the Digitek tablets manufactured at the New Jersey Actavis facility occurred because tablets may have been commercially released in the U.S. market with double the thickness of the normal sized tablets. [read post]
23 Jun 2011, 11:16 pm
Reddys Laboratories Mylan Pharmaceuticals Teva Aurobindo Pharma Glenmark Generics Lupin Wockhardt These companies and others are now allowed to sell their versions of Levaquin in the United States, which so far has earned $ 1.45 billion for a period of 12 months ending in September, 2010. [read post]
16 Jan 2009, 5:00 am
(IP finance) US: Medarex, Eurand and Alexion file actions against Director Dudas seeking revised patent term adjustment determinations (Patent Docs) US: Kubin panel questions motivation behind reversal in new Written Description Training Materials (Patent Docs) US: The obviousness of DNA - Federal Circuit heard oral argument for In re Kubin last week (Patent Docs) Products Antara (Fenofibrate) – US: Oscient and Ethypharm file patent infringement suit against Lupin over Antara… [read post]
23 Dec 2009, 12:40 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://duncanbucknell.com/subscribe/ Highlights this week included: Zyprexa (Olanzapine) – UK: Court of Appeal upholds Justice Floyd’s decision finding Olanzapine patent valid: Dr Reddy’s Laboratories v Eli Lilly (EPLAW) (IPKat) (Managing IP) (PatLit) (GenericsWeb) France: Pharma trade marks under threat - Senate and National Assembly approve law that would allow generic companies… [read post]
23 Jun 2014, 7:45 am
The wife of the decedent filed a lawsuit in federal court under diversity jurisdiction against GSK and Mylane, who is the maker of paroxetine, which was part of the medicine taken by the decedent. [read post]
26 Sep 2008, 7:23 pm
At the time of the JPMDL hearing in late July 2008 concerning the issue of whether a federal court Digitek MDL was necessary, there were at least 60 lawsuits which had been filed against Actavis Totowa, LLC and Mylan Pharmaceuticals, Inc., as well as numerous other corporate entities related to Acatavis and Mylan. [read post]
3 Jun 2010, 5:35 am
– In re Ciprofloxacin Antitrust Litigation (PatLit) Circumvent PCV and Porcilis PCV vaccines – US: Wyeth files patent infringement suit against Intervet based on their manufacture of PCV vaccines (Patent Docs) Copegus (Ribavirin) – US: Ascio seeks declaratory judgment of unenforceability, invalidity and non-infringement of Three Rivers’ patent based on ANDA filing (Patent Docs) Entocort (Budesonide) – US: AstraZeneca settles Entocort patent suit with Teva, stipulates… [read post]
8 Sep 2011, 12:59 pm
Government Bloomberg News reports that Par Pharmaceutical Cos., a maker and distributor of generic drugs, engaged in an illegal drug- switching scheme to increase sales, the U.S. said in a lawsuit in which two Mylan Inc. units are also accused by a whistleblower of wrongdoing. [read post]
28 Jul 2008, 7:01 pm
Mylan Laboratories, Inc., 520 F.3d 1358, 1364 (Fed. [read post]
15 May 2019, 5:27 am
Besides Teva, also Sandoz, Novartis, Mylan and Pfizer are mentioned, among others. [read post]
22 Dec 2020, 7:15 am
Based on SPC FR08C0020, Gilead decided to take action for infringement against Mylan, which launched TENOFOVIR DISOPROXIL, a generic of TRUVADA®. [read post]
24 Jun 2011, 12:44 pm
They eventually concluded that this was down to the size of the particles making up the input active pharmaceutical ingredient (the “API”) used in the US trials. [read post]
9 Aug 2011, 9:50 am
Mylan Pharmaceuticals, Inc., 696 F.Supp.2d 599 (N.D.W. [read post]
8 Nov 2020, 9:37 am
Hague District Court grants cross-border preliminary injunction against Mylan in Novartis SPC battle | Invalidating a patent after expiry of the patent term? [read post]
19 Aug 2020, 12:40 am
This Kat has sufficiency (of mice) objectionsWelcome to the latest IPKat roundup, which should especially cheer fans of patent news and views.PatentsKodak's most recent endeavours, by way of an announced pivot to generic pharmaceutical manufacturing thanks to a US government COVID-response loan, swiftly followed by an insider trading investigation which put the loan on hold, drew comment from PermaKat Neil Wilkof.In news from Australia, GuestKat Rose Hughes reported on the confirmation… [read post]
3 Jun 2013, 1:30 am
June 12, 2013 - 2 PM: Mylan Inc. v. [read post]
9 Jun 2014, 2:28 pm
He did however dismiss the claims against Mylan Inc., the generic drug maker. [read post]
17 Jun 2009, 3:02 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: Gene patenting debate continues: UCLA v USPTO (Patent Docs) (Patent Docs) (PatentlyBIOtech) (Patent Docs) (IP Watchdog) US: FTC issues highly anticipated report on follow-on biologics; report concludes that special legislative exclusivity incentives are largely unwarranted for innovators and generics (FDA Law Blog) (Patent Docs) (Patent Docs)… [read post]
